Dry Eye and Sustained Release Therapies

Dry Eye and Sustained Release Therapies is organized by Evolve Medical Education (EME) LLC.

Release Date: Feb 01, 2021
Expiration Date: Jan 26, 2024

Description:
Despite the routine use of antibiotics, corticosteroids, and nonsteroidal anti-inflammatory (NSAID) agents in postoperative ophthalmic surgical care, there remain issues with drug delivery of these agents. Ongoing education about novel corticosteroids and technologies is warranted to ensure eye care providers can deliver the best patient care possible.

All education activities identified in this education design document will be targeted to ophthalmologists and optometrists. The following categories of doctors have been identified as those with the greatest need for this educational intervention:
• Ophthalmologists who perform ophthalmic surgery.
• Ophthalmologists involved in the management of ocular inflammation following ophthalmic surgery.
• Optometrists who comanage patients following cataract surgery.

Learning Objectives:
At the completion of this educational activity, you will be better able to:

• Identify the issues surrounding patient adherence and compliance with topical medications after ocular surgery.
• Discuss the role of inflammation and ocular surface disease in chronic ocular diseases commonly treated with topical medications.
• Compare the drug delivery properties of novel sustained-release medications.
• Interpret and explain to patients the latest available treatments and determine which option is best for each patient.
• Describe how federal regulations on reimbursement affect practices as well as patients being treated for pain and inflammation associated with ophthalmic surgery.